Advances in the treatment of lung cancer

Breast cancer stem cells

Detection and treatment of mesothelioma

Preventive treatment for breast cancer

Adaptive design for clinical trials

MicroRNAs as novel therapeutic targets

Environmental tobacco smoke in relation to bladder cancer risk

Attributable risks for hepatocellular carcinoma in the USA

BMI, plasma C-peptide and smoking levels predict prostate cancer outcome

Metabolic pathway genes and bladder cancer risk

Weight gain is associated with an increased risk of prostate cancer recurrence in the PSA era

Advances in breast cancer treatments